109 related articles for article (PubMed ID: 15102519)
1. Production of prostaglandinE2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells.
Kawabe A; Shimada Y; Soma T; Maeda M; Itami A; Kaganoi J; Kiyono T; Imamura M
Life Sci; 2004 May; 75(1):21-34. PubMed ID: 15102519
[TBL] [Abstract][Full Text] [Related]
2. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
[TBL] [Abstract][Full Text] [Related]
3. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
[TBL] [Abstract][Full Text] [Related]
4. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
5. Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux.
Sung MW; Roh JL; Park BJ; Park SW; Kwon TK; Lee SJ; Kim KH
Laryngoscope; 2003 Jun; 113(6):1059-63. PubMed ID: 12782823
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
[TBL] [Abstract][Full Text] [Related]
8. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
[TBL] [Abstract][Full Text] [Related]
10. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids.
Zhang F; Altorki NK; Wu YC; Soslow RA; Subbaramaiah K; Dannenberg AJ
Gastroenterology; 2001 Dec; 121(6):1391-9. PubMed ID: 11729118
[TBL] [Abstract][Full Text] [Related]
11. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
[TBL] [Abstract][Full Text] [Related]
12. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.
Lord RV; Danenberg KD; Danenberg PV
Am J Gastroenterol; 1999 Aug; 94(8):2313-5. PubMed ID: 10445576
[No Abstract] [Full Text] [Related]
15. Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells.
Bando Y; Noguchi K; Kobayashi H; Yoshida N; Ishikawa I; Izumi Y
J Periodontal Res; 2009 Jun; 44(3):395-401. PubMed ID: 19210337
[TBL] [Abstract][Full Text] [Related]
16. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats.
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T; Koichi M
Carcinogenesis; 2005 Mar; 26(3):565-70. PubMed ID: 15564290
[TBL] [Abstract][Full Text] [Related]
17. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells.
Arikawa T; Omura K; Morita I
J Cell Physiol; 2004 Sep; 200(3):400-6. PubMed ID: 15254968
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 27: induction by gastroduodenal reflux in vivo and augmentation of human esophageal mucosal cell growth in vitro.
Mauchley D; Meng X; Johnson T; Teitelbaum J; Babu A; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1019-25. PubMed ID: 20304146
[TBL] [Abstract][Full Text] [Related]
19. Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent.
Kaur BS; Triadafilopoulos G
Am J Physiol Gastrointest Liver Physiol; 2002 Aug; 283(2):G327-34. PubMed ID: 12121879
[TBL] [Abstract][Full Text] [Related]
20. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]